Copy
View this email in your browser
Vol. 2, No. 16                                                                                                               August 7, 2019

Cancer Institute Member Spotlight


Tom Kelly, Ph.D.
Associate Professor 
Department of Pathology

UAMS College of Medicine

 
Dr. Kelly works with Steve Post, Ph.D., on the role of tumor-associated macrophages and scavenger receptor-A (SR-A) in promoting the rapid formation and outgrowth of tumors that we observe in the in vivo mammary tumor virus-polyoma middle T (MMTV-PyMT) model of breast cancer. Read more>
Sylvester Comprehensive Cancer Center Named 71st NCI-Designated Center

After six years of aggressively recruiting and spending more than $250 million to build up its programs, Sylvester Comprehensive Cancer Center has become the 71st NCI-Designated cancer center in the United States. The designation was announced July 29. Read an interview with Stephen Nimer, M.D., Sylvester director, in The Cancer Letter, a subscription-based online publication made available to UAMS employees by the Cancer Institute.
AACI-Clinical Research Innovation Forum Update
The Association of American Cancer Institutes hosted its annual Clinical Research Innovation forum in Chicago from July 9-11, 2019. More than 430 clinical research leaders, medical directors, cancer center administrators, patient advocates, NCI representatives and industry representatives attended to discuss best practices to promote efficient operation of clinical research programs. 

The forum draws attendees from cancer centers that have already achieved NCI designation and those that are pursuing it.
The Winthrop P. Rockefeller Cancer Institute was represented by Dorothy Graves, Ph.D., associate director for administration; Kristin Zorn, M.D., associate director for clinical research; and Alexandra “Sandy” Annis, C.C.R.P., executive director for cancer clinical trials and regulatory affairs. In addition, Sandy participated in a panel presentation about monitoring the post-activation stage of clinical trial management among clinical trial offices of various sizes. 
KL2 Scholars Include 2 Cancer-Related Projects
The UAMS Translational Research Institute has awarded five early-career UAMS researchers with KL2 Mentored Research Career Development Program Scholar Awards.

The program provides two years of instruction and mentored research training. Scholars receive 75% salary support and up to $25,000 per year for research, tuition, travel expenses and education materials. Read more>
Know someone who needs to be added to our email list? Send their name to Susan Van Dusen, communications manager.
Copyright © 2020 Winthrop P. Rockefeller Cancer Institute, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp